Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme - PubMed (original) (raw)

. 1998 Apr 10;243(2):406-14.

doi: 10.1006/viro.1998.9072.

Affiliations

• PMID: 9568039
• DOI: 10.1006/viro.1998.9072

Free article

Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme

C Rivas et al. Virology. 1998.

Free article

Abstract

Induction of apoptosis in mammalian cells by double-stranded (ds) RNA-dependent enzymes, protein kinase (PKR), and 2-5A-synthetase/RNase L (referred to as the 2-5A system) might be a mechanism mediating anticellular and antiviral actions of interferon (i.f.n.). To counteract the effect of i.f.n., animal viruses have acquired genes that block specific i.f.n. pathways. Among poxviruses, vaccinia virus (VV) encodes E3L, a dsRNA-binding protein, which inhibits activation of i.f.n.-induced PKR. It has been proposed that E3L might also block activation of the 2-5A system, but direct proof is lacking. To establish if E3L inhibits the 2-5A system, we have developed a method to assay apoptosis induced by increased production of enzymes in the 2-5A pathway, as well as of their putative modulators. This assay is based on the use of cells derived from homozygous PKR knockout mice (Pkr-/-) infected with a VV mutant lacking E3L (delta E3L) and transiently transfected with a luciferase reporter gene together with plasmid vectors expressing 2-5A-synthetase, RNase L, or E3L, all controlled by the same inducible promoter. We found that expression of 2-5A-synthetase inhibited luciferase activity in a dose-response manner, reaching inhibition values of 80% relative to transfections with control plasmids. Similar results were obtained by transfection with an RNase L vector, although in this case the extent of inhibition was further enhanced upon coexpression of 2-5A-synthetase and RNase L. Inhibition of protein synthesis mediated by the 2-5A system correlated well with induction of apoptosis. Transfection of cells with a plasmid vector expressing E3L together with 2-5A-synthetase completely prevented apoptosis induced by this enzyme. We conclude that VV E3L acts as an inhibitor of the i.f.n.-induced 2-5A-synthetase enzyme.

PubMed Disclaimer

Similar articles

• Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication.
  Díaz-Guerra M, Rivas C, Esteban M. Díaz-Guerra M, et al. Virology. 1997 Jan 6;227(1):220-8. doi: 10.1006/viro.1996.8294. Virology. 1997. PMID: 9007077
• Roles of vaccinia virus genes E3L and K3L and host genes PKR and RNase L during intratracheal infection of C57BL/6 mice.
  Rice AD, Turner PC, Embury JE, Moldawer LL, Baker HV, Moyer RW. Rice AD, et al. J Virol. 2011 Jan;85(1):550-67. doi: 10.1128/JVI.00254-10. Epub 2010 Oct 13. J Virol. 2011. PMID: 20943971 Free PMC article.
• Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus.
  Xiang Y, Condit RC, Vijaysri S, Jacobs B, Williams BR, Silverman RH. Xiang Y, et al. J Virol. 2002 May;76(10):5251-9. doi: 10.1128/jvi.76.10.5251-5259.2002. J Virol. 2002. PMID: 11967338 Free PMC article.
• Vaccinia virus recombinants as a model system to analyze interferon-induced pathways.
  Gil J, Esteban M. Gil J, et al. J Interferon Cytokine Res. 2004 Nov;24(11):637-46. doi: 10.1089/jir.2004.24.637. J Interferon Cytokine Res. 2004. PMID: 15684816 Review.
• New insights into the role of RNase L in innate immunity.
  Chakrabarti A, Jha BK, Silverman RH. Chakrabarti A, et al. J Interferon Cytokine Res. 2011 Jan;31(1):49-57. doi: 10.1089/jir.2010.0120. Epub 2010 Dec 29. J Interferon Cytokine Res. 2011. PMID: 21190483 Free PMC article. Review.

Cited by

• Human monkeypox and smallpox viruses: genomic comparison.
  Shchelkunov SN, Totmenin AV, Babkin IV, Safronov PF, Ryazankina OI, Petrov NA, Gutorov VV, Uvarova EA, Mikheev MV, Sisler JR, Esposito JJ, Jahrling PB, Moss B, Sandakhchiev LS. Shchelkunov SN, et al. FEBS Lett. 2001 Nov 30;509(1):66-70. doi: 10.1016/s0014-5793(01)03144-1. FEBS Lett. 2001. PMID: 11734207 Free PMC article.
• Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist.
  Ye Y, Hauns K, Langland JO, Jacobs BL, Hogue BG. Ye Y, et al. J Virol. 2007 Mar;81(6):2554-63. doi: 10.1128/JVI.01634-06. Epub 2006 Dec 20. J Virol. 2007. PMID: 17182678 Free PMC article.
• The double-stranded RNA binding domain of the vaccinia virus E3L protein inhibits both RNA- and DNA-induced activation of interferon beta.
  Marq JB, Hausmann S, Luban J, Kolakofsky D, Garcin D. Marq JB, et al. J Biol Chem. 2009 Sep 18;284(38):25471-8. doi: 10.1074/jbc.M109.018895. Epub 2009 Jul 7. J Biol Chem. 2009. PMID: 19584049 Free PMC article.
• Regulation of vaccinia virus E3 protein by small ubiquitin-like modifier proteins.
  González-Santamaría J, Campagna M, García MA, Marcos-Villar L, González D, Gallego P, Lopitz-Otsoa F, Guerra S, Rodríguez MS, Esteban M, Rivas C. González-Santamaría J, et al. J Virol. 2011 Dec;85(24):12890-900. doi: 10.1128/JVI.05628-11. Epub 2011 Sep 28. J Virol. 2011. PMID: 21957283 Free PMC article.
• Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome.
  Bolinger C, Boris-Lawrie K. Bolinger C, et al. Retrovirology. 2009 Jan 24;6:8. doi: 10.1186/1742-4690-6-8. Retrovirology. 2009. PMID: 19166625 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database